Literature DB >> 19759118

Clinical imaging characteristics of the positron emission mammography camera: PEM Flex Solo II.

Lawrence MacDonald1, John Edwards, Thomas Lewellen, David Haseley, James Rogers, Paul Kinahan.   

Abstract

UNLABELLED: We evaluated a commercial positron emission mammography (PEM) camera, the PEM Flex Solo II. This system comprises two 6 x 16.4 cm detectors that scan together covering up to a 24 x 16.4 cm field of view (FOV). There are no specific standards for testing this detector configuration. We performed several tests important to breast imaging, and we propose tests that should be included in standardized testing of PEM systems.
METHODS: We measured spatial resolution, uniformity, counting- rate linearity, recovery coefficients, and quantification accuracy using the system's software. Image linearity and coefficient of variation at the edge of the FOV were also characterized. Anecdotal examples of clinical patient data are presented.
RESULTS: The spatial resolution was 2.4 mm in full width at half maximum for image planes parallel to the detector faces. The background variability was approximately 5%, and quantification accuracy and recovery coefficients varied within the FOV. Positioning linearity began at approximately 13 mm from the edge of the detector housing. The coefficient of variation was significantly higher close to the edge of the FOV because of limited sensitivity in these image planes.
CONCLUSION: A reconstructed spatial resolution of 2.4 mm represented a significant improvement over conventional whole-body PET scanners and should reduce the lower threshold on lesion size and tracer uptake for detection in the breast. Limited-angle tomography and a lack of data corrections result in spatially variable quantitative results. PEM acquisition geometry limits sampling statistics at the chest-wall edge of the camera, resulting in high variance in that portion of the image. Example patient images demonstrate that lesions can be detected at the chest-wall edge despite variance artifacts, and fine structure is visualized routinely throughout the FOV in the focal plane. The PEM Flex camera should enable the functional imaging of breast cancer earlier in the disease process than whole-body PET.

Entities:  

Mesh:

Year:  2009        PMID: 19759118      PMCID: PMC2873041          DOI: 10.2967/jnumed.109.064345

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

1.  Anatomy of SUV. Standardized uptake value.

Authors:  S C Huang
Journal:  Nucl Med Biol       Date:  2000-10       Impact factor: 2.408

Review 2.  Digital x-ray tomosynthesis: current state of the art and clinical potential.

Authors:  James T Dobbins; Devon J Godfrey
Journal:  Phys Med Biol       Date:  2003-10-07       Impact factor: 3.609

3.  NEMA NU 2 performance tests for scanners with intrinsic radioactivity.

Authors:  Charles C Watson; Michael E Casey; Lars Eriksson; Tim Mulnix; Doug Adams; Bernard Bendriem
Journal:  J Nucl Med       Date:  2004-05       Impact factor: 10.057

Review 4.  Current and future uses of positron emission tomography in breast cancer imaging.

Authors:  William B Eubank; David A Mankoff
Journal:  Semin Nucl Med       Date:  2004-07       Impact factor: 4.446

5.  The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements.

Authors:  Raymond R Raylman; Stan Majewski; Mark F Smith; James Proffitt; William Hammond; Amarnath Srinivasan; John McKisson; Vladimir Popov; Andrew Weisenberger; Clifford O Judy; Brian Kross; Srikanth Ramasubramanian; Larry E Banta; Paul E Kinahan; Kyle Champley
Journal:  Phys Med Biol       Date:  2008-01-10       Impact factor: 3.609

6.  Feasibility study for positron emission mammography.

Authors:  C J Thompson; K Murthy; I N Weinberg; F Mako
Journal:  Med Phys       Date:  1994-04       Impact factor: 4.071

7.  Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.

Authors:  L Tabár; B Vitak; H H Chen; M F Yen; S W Duffy; R A Smith
Journal:  Cancer       Date:  2001-05-01       Impact factor: 6.860

8.  Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.

Authors:  R L Wahl; R L Cody; G D Hutchins; E E Mudgett
Journal:  Radiology       Date:  1991-06       Impact factor: 11.105

9.  Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.

Authors:  N Avril; C A Rosé; M Schelling; J Dose; W Kuhn; S Bense; W Weber; S Ziegler; H Graeff; M Schwaiger
Journal:  J Clin Oncol       Date:  2000-10-15       Impact factor: 44.544

10.  Positron emission mammography: initial clinical results.

Authors:  Edward A Levine; Rita I Freimanis; Nancy D Perrier; Kathryn Morton; Nadia M Lesko; Simon Bergman; Kim R Geisinger; Rodney C Williams; Connie Sharpe; Valera Zavarzin; Irving N Weinberg; Pavel Y Stepanov; David Beylin; Kathryn Lauckner; Mohan Doss; Judy Lovelace; Lee P Adler
Journal:  Ann Surg Oncol       Date:  2003 Jan-Feb       Impact factor: 5.344

View more
  39 in total

1.  Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancer.

Authors:  Alessandra Gennari; Arnoldo Piccardo; Vania Altrinetti; Davide Corradengo; Giampiero Villavecchia; Andrea De Censi
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Investigating the limit of detectability of a positron emission mammography device: a phantom study.

Authors:  Nicholas A Shkumat; Adam Springer; Christopher M Walker; Eric M Rohren; Wei T Yang; Beatriz E Adrada; Elsa Arribas; Selin Carkaci; Hubert H Chuang; Lumarie Santiago; Osama R Mawlawi
Journal:  Med Phys       Date:  2011-09       Impact factor: 4.071

3.  Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.

Authors:  Wendie A Berg; Kathleen S Madsen; Kathy Schilling; Marie Tartar; Etta D Pisano; Linda Hovanessian Larsen; Deepa Narayanan; Al Ozonoff; Joel P Miller; Judith E Kalinyak
Journal:  Radiology       Date:  2010-11-12       Impact factor: 11.105

4.  A generalized reconstruction framework for unconventional PET systems.

Authors:  Aswin John Mathews; Ke Li; Sergey Komarov; Qiang Wang; Bosky Ravindranath; Joseph A O'Sullivan; Yuan-Chuan Tai
Journal:  Med Phys       Date:  2015-08       Impact factor: 4.071

5.  Improving PET imaging for breast cancer using virtual pinhole PET half-ring insert.

Authors:  Aswin John Mathews; Sergey Komarov; Heyu Wu; Joseph A O'Sullivan; Yuan-Chuan Tai
Journal:  Phys Med Biol       Date:  2013-09-02       Impact factor: 3.609

6.  Quantification with a dedicated breast PET/CT scanner.

Authors:  Spencer L Bowen; Andrea Ferrero; Ramsey D Badawi
Journal:  Med Phys       Date:  2012-05       Impact factor: 4.071

Review 7.  Innovations in Instrumentation for Positron Emission Tomography.

Authors:  Eric Berg; Simon R Cherry
Journal:  Semin Nucl Med       Date:  2018-03-12       Impact factor: 4.446

8.  DOI-based reconstruction algorithms for a compact breast PET scanner.

Authors:  Kyle M Champley; Lawrence R MacDonald; Thomas K Lewellen; Robert S Miyaoka; Paul E Kinahan
Journal:  Med Phys       Date:  2011-03       Impact factor: 4.071

9.  High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.

Authors:  Abhijit J Chaudhari; Andrea Ferrero; Felipe Godinez; Kai Yang; David K Shelton; John C Hunter; Stanley M Naguwa; John M Boone; Siba P Raychaudhuri; Ramsey D Badawi
Journal:  Br J Radiol       Date:  2016-04-25       Impact factor: 3.039

10.  Correlation of PUV and SUV in the extremities while using PEM as a high-resolution positron emission scanner.

Authors:  Sania Rahim; Osama Mawlawi; Patricia Fox; Shree Taylor; Richelle Millican; Nancy M Swanston; J Elliott Brown; Eric M Rohren
Journal:  Skeletal Radiol       Date:  2014-01-16       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.